premium content
Buy Yourgene - target 0.6p
On 21st December, with its shares having previously closed at 1.85p, Yourgene Health* (YGEN) announced a “capital raising” for “not less than £5.0 million” stated to “provide near-term working capital; and facilitate further restructuring of the group's cost base, removing £2.0 million of annual operating expenditure. The company will also utilise any additional net proceeds to fund regulatory approvals and existing product enhancements”. I.e. it was cash crunch ahoy and, having left the fundraise to that point and with stock market conditions dreadful, the raising was at… 0.30p per share! Unsurprisingly, that sunk the shares, but with new capital now raised and sentiment arguably having hit rock bottom, we see some good recovery potential from a current 0.38p offer price. (now 0.41p)- By Hotstockrockets |
- 22 January 2023, 13:18 |
premium content
Ariana – 2022 Production Result: A Top Effort: Buy
AIM-listed Turkish Gold producer Ariana Resources (AAU) released its production results on Friday along with a general update. The news was excellent and the shares surged (as much as Ariana shares ever surge!) higher but there is more to go.- By Nigel Somerville |
- 22 January 2023, 11:08 |
Visual Aid: Which countries are the most polarised?
From Visual Capitalist, this week’s graphic is based on the 2023 Edelman Trust Barometer. It says the US is hopeless, as is Argentina, Span, and Sweden. The UK is at risk.- By Darren Atwater |
- 22 January 2023, 10:27 |
premium content
Prospects for investment (and travel) remain good…but the scope for a saga at Saga continues
I read in the Sunday press that Saga (SAGA) - the holiday, insurance and more company focused on serving the needs of those aged 50 and over - is allegedly “sounding out buyers for its in-house insurance business in the hope of raising up to £90 million to pay down debt”. It definitely needs to be considering some options there as the last time I looked, its net debt to EBITDA ratio was a mere x8.5 times.- By Chris Bailey of Financial Orbit |
- 22 January 2023, 10:23 |
premium content
Sunday Long Reads: Bike Helmets, Pandemic Pastor, Dungeons & Dragons, $6 Tennis Pro, UK vs Metric
Here are five long reads that have nothing to do with shares. Put the kettle on, find a comfy chair. You have the time, don't you?
- By Darren Atwater |
- 22 January 2023, 10:15 |
Notes from Underground – Most read articles for the week ending 22 Jan 2023
The most-read non-quiz non-Tom article this week is by Nigel Somerville with Centamin – Court Win Secures Mine Concession Agreement: BUY at No 5 or No 11 including Bearcasts.
- By Darren Atwater |
- 22 January 2023, 10:14 |
premium content
Tom Winnifrith Bearcast: Kefi and its shareholders again: aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaagh
In today's podcast I look at the critical difference between the Standard List & Aquis and the AIM sewer and why advisers like Andrew Monk are thus anti AIM. I am not so sure. Then I look at Kefi (KEFI) some of whose shareholders who just do not understand insider dealing laws are doing my head in.- By Tom Winnifrith |
- 21 January 2023, 18:22 |
premium content
Shanta Gold – 2022 production and operational results, BUY (target 16p)
Shanta Gold (SHG) has announced 2022 production and operational results and that “there are numerous initiatives underway and in place for 2023 to decrease operational risks and optimise production”.- By Hotstockrockets |
- 21 January 2023, 15:35 |
premium content
Note to Andrew Monk: Rule Breaking by your client Caracal Gold
I have today written to “the monkey” the boss of VSA Capital, advisors to Caracal Gold (GCAT) which has driven a coach and horses through the rule book of the Standard List. Does Monkey care? Does he think he has a reputation to lose by not caring? Or are those unpaid fees to VSA more important than salvaging what is left of its reputation? When will it fess? The letter to Monk is below- By Tom Winnifrith |
- 21 January 2023, 15:24 |
Capital Limited – 2022 trading update and confidence in the demand: BUY
Africa-focused mining services company Capital (CAPD) has issued a trading update for the 2022 calendar year and emphasised that it remains confident in the demand it is seeing on the ground.- By Hotstockrockets |
- 21 January 2023, 14:04 |
premium content
Centamin – Q4 and full-year update, a progressing gold BUY
Centamin (CEY) has issued an update on the fourth quarter and full-year of 2022, including emphasising that it is now looking forward to further increasing gold production while continuing to manage cost pressures and progressing the multiple identified opportunities across its portfolio.- By Tom Winnifrith & Steve Moore |
- 21 January 2023, 12:21 |
premium content
Zephyr Energy what is a bridging loan? An admission that a placing is on the way?
You and I understand that a bridging loan is one that will be refinanced and is short term by nature. We need one to buy a house when our old one is yet to sell. So how does Zephyr Energy (ZPHR) define a bridging loan.- By Tom Winnifrith |
- 21 January 2023, 11:21 |
Footsie Riding High but this Time that's Not Great News for us All.
Hello Share Sharers. So the Footsie has been rising and is now tickling all-time highs. But it would have been much healthier if it had not been for Covid. And those of us who merely hung onto shares, rather than actively buying and selling them, have seen very little profit for a long time now. We should also realise that a currently high Footsie doesn't mean everything in the garden is rosy.premium content
NIOX – positive 2022 trading statement, not long to be able to buy at these levels?
Medical devices group NIOX (NIOX) has issued a trading statement for the 2022 calendar year and that “sales of NIOX devices and tests continued to improve”.- By HotStockRockets |
- 20 January 2023, 16:49 |
premium content
In The Style Group – “trading update” further suggests CEO’s stated ‘absolute confidence’ is wrong
Previously writing on group which described itself as a “disruptive and inclusive digital womenswear fashion brand” In The Style (ITS), I reviewed what of a now 13.625p share price as the CEO swiftly exited and a strategic review was announced but it argued “considerable potential… the current market capitalisation of the company does not properly reflect”? I concluded, noting its trading trajectory, reiterating to avoid… and now an intra-day (uh oh!), 12:54pm, “trading update”.
- By Steve Moore |
- 20 January 2023, 16:29 |
premium content
Tom Winnifrith Bearcast: Zamaz shares collapse, the FCA disgraces itself again
In today's Bearcast I look at Zamaz (ZAMZ), Love Hemp (LIFE), Mirriad (MIRI) and in depth at Versarien (VRS) as its shares slide again ahead of what will be appalling results and an auditors warning within 10 days. Neill Ricketts...it could not happen to a nicer bloke.- By Tom Winnifrith |
- 20 January 2023, 15:09 |
premium content
Seraphine – recommended offer by the robber barons of Mayfair Equity Partners, another London Stock Exchange covid-era disgrace
An announcement from maternity and nursing wear group Seraphine (BUMP) that its “independent directors are pleased to announce that they have reached agreement on the terms of a recommended cash offer to be made by… a wholly-owned indirect subsidiary of funds managed by Mayfair Equity Partners LLP”. It states this including with that the 30p per share, £15.3 million, offer “represents a premium of approximately… 206 per cent to the closing price per Seraphine share of 9.8 pence on 19 January 2023”. However, the group only listed in July 2021… at 295p per share! And that was with a controlling shareholder… Mayfair Equity Partners!- By Steve Moore & Tom Winnifrith |
- 20 January 2023, 15:09 |
premium content
Mirriad puts itself up for sale as it admits it is running out of cash ( again)
Mirriad Advertising (MIRI) today uttered the two words that should strike fear into the hearts of all investors: “strategic review.” That is stockmarket speak for “the game is up we are fucked.” Sure it tried to sugar the pill by initiating a formal sales process (FSP) and putting itself up for sale. Hey Cheryl darling I am waiting, ready, free and available.- By Tom Winnifrith |
- 20 January 2023, 14:09 |
premium content
Supply@Me Capital – joke trading update, deep dive into the waffle, Part 2
As I pointed out earlier, in today’s trading update the fraud Supply@ ME Capital (SYME) provides no financial information on revenues or cash as at 31 December 2022 because boss Alessandro Zamboni doesn’t want to expose just how piss poor the actual numbers are. The trading statement has a list of “achievements” but its primarily a list of excuses of that the dog ate my homework during 2022 but there will be jam tomorrow. Now to dig into the excuses…- By Tom Winnifrith |
- 20 January 2023, 13:25 |
premium content
Hotel Chocolat is going to need a very sweet 2023
A couple of weeks ago I concluded that “Chocolate is a sweet treat but you still cannot say the same for Hotel Chocolat (HOTC) shares” HERE. Despite a big share price fall in 2022, the then c. two quid share price, after an early January hope romp, seemed bonkers to me. It is just over 220p now as, apparently, it had a great Christmas trading session.
- By Chris Bailey |
- 20 January 2023, 13:10 |